[Study of combined therapy of parkinsonian conditions, especially postencephalitic conditions].
D001337:Autonomic Agents / Q000627:therapeutic use*; D009125:Muscle Relaxants, Central / Q000627:therapeutic use*; D010300:Parkinson Disease / Q000628:therapy*; D020734:Parkinsonian Disorders; D014282:Trihexyphenidyl / Q000627:therapeutic use*
D001337:Autonomic Agents; D009125:Muscle Relaxants, Central; D014282:Trihexyphenidyl
AUTONOMIC DRUGS/therapeutic use; MUSCLE RELAXANTS/therapeutic use; PARALYSIS AGITANS/therapy; TRIHEXYPHENIDYL/therapeutic use
Ein Beitrag zur kombinierten Therapie parkinsonistischer -speziell postencephalitischer - Zustände.